DUAL GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE/GLUCAGON-LIKE PEPTIDE-1 RECEPTOR CO-AGONISTS As part of the ongoing effort to use synergistic effects of gastrointestinal hormones in the treatment of diabetes and obesity, the first GIP/GLP-1 receptor co-agonist was reported in 2013
Dosing & Reconstitution Guide Educational guide for reconstitution and weekly dosing Standard / Gradual Approach (3 mL = ~10.0 mg/mL) Frequency: Inject once weekly subcutaneously [1] [2]
Bacteriostatic water for injection is a sterile, nonpyrogenic water that contains 0.9%-1.1% (9-11 mg/mL) benzyl alcohol as a bacteriostatic preservative
doi: 10.3389/fped.2024.1499644 Received 21 September 2024 Accepted 18 November 2024 Published 06 December 2024 Volume 12 - 2024 Edited by Aydin Yagmurlu, Ankara University, Trkiye Reviewed by Elisa Cerchia, Regina Margherita Children Hospital, Italy Burak Tander, Acbadem University, Trkiye Updates Copyright 2024 Ji, Zhao, Xi and Ren
"Insulin resistance and endothelial function are improved after folate and vitamin B12 therapy in patients with metabolic syndrome: relationship between homocysteine levels and hyperinsulinemia"
By injecting vitamins directly into the bloodstream, the body is flooded with powerful, prescription-grade nutrients that provide an energetic boost nearly immediately
